StockData
OS Therapies Inc logo

OS Therapies Inc (OSTX) stock

OSTXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.92+0.18 (+23.51%)

Close on Nov 18, 2026Market cap $42.43MP/E –Yield –

OS Therapies free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

OS Therapies's free cash flow for the twelve months ending Dec 31, 2025 was -$14.70M. For fiscal 2025 it was -$14.70M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$14.70M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025-$3.73M–
Q3 FY2025Sep 30, 2025-$4.71M–
Q2 FY2025Jun 30, 2025-$2.68M–
Q1 FY2025Mar 31, 2025-$3.59M–
Q3 FY2023Sep 30, 2023-$876.57K–

More OS Therapies figures

See a number that looks wrong?